Centessa Pharmaceuticals plc - ADR
News
Centessa Pharmaceuticals announces $150M proposed public offering of American Depositary Shares
Seeking Alpha - Healthcare Centessa Pharmaceuticals announces $150M proposed public offering of American Depositary Shares...\n more…
Centessa Pharmaceuticals Announces $150,000,000 Proposed Public Offering of American Depositary Shares
Globe Newswire BOSTON and LONDON, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are...\n more…
Centessa Pharmaceuticals (NASDAQ:CNTA) PT Raised to $20.00 at BMO Capital Markets
Ticker Report Centessa Pharmaceuticals (NASDAQ:CNTA - Get Free Report) had its price objective increased by investment analysts at BMO Capital Markets from $15.00 to $20.00 in a research report issued to clients...\n more…
Centessa Pharmaceuticals (NASDAQ:CNTA) Shares Gap Up After Analyst Upgrade
Ticker Report Centessa Pharmaceuticals plc (NASDAQ:CNTA - Get Free Report)'s share price gapped up prior to trading on Tuesday after BMO Capital Markets raised their price target on the stock from $15.00 to...\n more…
Centessa Announces Positive Interim Phase 1 Clinical Data with its Novel Orexin Receptor 2 (OX2R) Agonist, ORX750, in Acutely Sleep-Deprived Healthy Volunteers
Globe Newswire 2.5 mg dose restored normative wakefulness with mean sleep latency of 32 minutes as measured by the Maintenance of Wakefulness Test (MWT)Favorable safety and tolerability profile with no observations...\n more…